SERPINE1 and cardiovascular disorder: −675 4G/5G PAI-1 promoter polymorphism is also reported to be associated with other cardiovascular diseases, including thrombosis [41], myocardial infarction [27, 36, 42] or coronary artery disease [43, 44].